Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1Phase 2 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 7NIH 3NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3

Conditions

Lymphoma 44Breast Neoplasms 26Sarcoma 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Burkitt Lymphoma 14Neuroblastoma 13Hodgkin Disease 13Leukemia 12Lymphoma, Large B-Cell, Diffuse 11Lymphoma, Follicular 8Wilms Tumor 7Sarcoma, Synovial 7Neurofibrosarcoma 7Leiomyosarcoma 7Histiocytoma, Malignant Fibrous 7Hemangiosarcoma 7Fibrosarcoma 7Endometrial Neoplasms 7Urinary Bladder Neoplasms 6Multiple Myeloma 6Malignant mesenchymal tumor 6Liposarcoma 6Rhabdomyosarcoma 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Anaplastic 5Kidney Neoplasms 5Hemangiopericytoma, Malignant 5Waldenstrom Macroglobulinemia 4Sarcoma, Alveolar Soft Part 4

Interventions

Vincristine 3Ifosfamide 3Etoposide 3Doxorubicin 3Cyclophosphamide 3Surgical Procedures, Operative 2Specimen Handling 2Radiotherapy 2Melphalan 2Irinotecan 2Busulfan 2regorafenib 1irinotecan sucrosofate 1X-Rays 1Trabectedin 1Temozolomide 1Radiation 1Phantoms, Imaging 1Magnetic Resonance Spectroscopy 1Fluorodeoxyglucose F18 1Dactinomycin 1Bone Density 1Biopsy 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Sarcoma, Ewing × Doxorubicin × Clear all
NCT06820957 2026-02-17

Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body

Children's Oncology Group

Phase 2/3 Active not recruiting
437 enrolled
Sarcoma

Sarcoma, Ewing

NCT02063022 2022-09-19

EW-1

Italian Sarcoma Group

Phase 3 Completed
278 enrolled
Sarcoma

Sarcoma, Ewing

NCT02727387 2022-09-19

EW-2

Italian Sarcoma Group

Phase 2 Completed
155 enrolled
Sarcoma

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡